A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian ...

During menopause, women often deal with biological, physical, and emotional issues — to help them lose weight, clinicians ...

You may have heard of “Ozempic face,” but some women who have taken Ozempic for weight loss are now reporting experiencing “Ozempic vulva” as well. In recent years, some people have started using ...

London-based startup SheMed, which offers personalized weight-loss plans using popular medicines Wegovy and Mounjaro, said on Thursday it has raised $50 million in its Series A funding round to expand ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone, ...

Some women are experiencing significant hair loss as a side effect of testosterone therapy and popular weight-loss drugs. Rapid weight loss from GLP-1 medications like Ozempic and Zepbound can trigger ...

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...

Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers. A new study has ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...